TreatmentThalidomide


Journal of Neuro-Oncology, 64 (3): 193-201, September 2003 (Cell Culture Study)


Abstract

Effects of Thalidomide on Parameters Involved in Angiogenesis: An in vitro Study

M. Gelati, E. Corsini, S. Frigerio, B. Pollo, G. Broggi, D. Croci, A. Silvani, A. Boiardi, A. Salmaggi

Istituto Nazionale Neurologico 'C.Besta', Milan, Italy

In an attempt to elucidate the mechanism(s) of action of thalidomide, a reportedly antiangiogenic molecule recently tested in the treatment of relapsing malignant gliomas, we performed an in vitro study on the following parameters: 
(a) effect of thalidomide on proliferation of endothelial cells; 
(b) effect of thalidomide on expression of
αvβ3 integrin on the surface of endothelial cells; 
(c) effect of thalidomide on the release by endothelial cells of MMP-2, IL-8 and TNF-
α
The results show that thalidomide inhibits endotelial cell proliferation induced by bFGF and VEGF, more so if the cells are grown on vitronectin; moreover, treatment with thalidomide reduces the release of MMP-2 and IL-8 by endothelial cells, suggesting a further pathway for the antiangiogenic activity of drug. 
On the other hand, thalidomide does not modify expression of
αvβ3 on endothelial cells.

Copyright © 2003 Kluwer Academic Publishers. All rights reserved

Source: http://www.kluweronline.com/issn/0167-594X/contents


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP